News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter
Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

Celebrities and Cancer
Cancer Types
Radiotherapy
Science
Trial Updates
ASCO
ESMO
ESO
MASCC
Cancer Center Near Me
Immune Oncology
Oncologist Near Me
OncoDaily Party 2025

Childhood Cancer
Health Policy
Hall of Fame
OncoIndustry
Public Health
Oncology Tech
Blog Posts
BIGR
Global Cancer Movement
History
Oncolibrary
OncoThon 2025
Yvonne Award 2025

Jan / 2026

January 2026
M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

« Dec

OncoDaily IO OncoDaily GI Hemostasis Today Fertility News

Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter

Jeffrey Bluestone: Kick-Ass Science, Collaborate Like Hell, Make a Difference

Jeffrey Bluestone: Kick-Ass Science, Collaborate Like Hell, Make a Difference

France Expands Reimbursed Compassionate Access for Botensilimab/Balstilimab to Ovarian Cancer and Soft-Tissue Sarcomas

France Expands Reimbursed Compassionate Access for Botensilimab/Balstilimab to Ovarian Cancer and Soft-Tissue Sarcomas

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

TWINPEAK study: Spevatamig Plus Gemcitabine and Nab-Paclitaxel as 1L Therapy in CLDN18.2 Positive mPDAC

TWINPEAK study: Spevatamig Plus Gemcitabine and Nab-Paclitaxel as 1L Therapy in CLDN18.2 Positive mPDAC

Radiation Therapy Toxicity Myth-Busting

Radiation Therapy Toxicity Myth-Busting

Beate Timmermann Has Been Elected Secretary of the Paediatric Radiation Oncology Society for 2026-2028

Beate Timmermann Has Been Elected Secretary of the Paediatric Radiation Oncology Society for 2026-2028

Merck Could Strike 30 Billion Deal for Revolution Medicines

Merck Could Strike 30 Billion Deal for Revolution Medicines

Qatar Launches New National Patient Safety Classification to Boost Care Quality

Qatar Launches New National Patient Safety Classification to Boost Care Quality

Swedish Foundation

Sep 21, 2024 2:54 pm

Blog Posts

Lacy Hubbard: Wrapping up an unforgettable final day at the World Cancer Congress

Cervical Cancer

Jun 2, 2024 9:17 am

Blog Posts

Sarah Greene: Invigorating to be featured in the Swedish Foundation story about my endometrial cancer experience

Sarah Greene

Headlines

CRI Discovery Engine Inaugurates New Chapter in Immunotherapy, Creating the First-of-its-Kind AI-Ready Database

Alexis Vandier is Appointed Global Head of Servier Ventures

Potential Anti-Cancer Fungal Compound Verticillin A Finally Synthesized After More Than 50 Years

Jennifer Marshall and Stage III Melanoma: Survival, Immunotherapy, and Life After Stranger Things

PAAG Trial: Integrating PD-1 Blockade and Antiangiogenic Therapy in Metastatic Pancreatic Cancer

CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

About Privacy Policy Editorial Policy Cookie Policy Disclaimer

Crafted by Matemat

Oncology OncoDaily cancer fight against cancer Global fight against cancer Breast Cancer cancer care ASCO Lung cancer Cancer research ESMO Headlines MD Anderson Cancer Center immunotherapy NSCLC cancer awareness cancer treatment Research ASCO24 colorectal cancer Childhood Cancer clinical trials prostate cancer AACR FDA UICC Dana-Farber Cancer Institute European Cancer Organisation American Cancer Society SIOP NCI chemotherapy Myeloma National Cancer Institute Robert Orlowski American Society of Clinical Oncology Vivek Subbiah healthcare Myeloma Paper of the Day Paolo Tarantino Pancreatic Cancer AI IASLC ASCO25 radiation oncology WHO multiple myeloma cervical cancer Memorial Sloan Kettering Cancer Center Zainab Shinkafi-Bagudu

European School of Oncology

Sitemap

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}